Global Bioanalytical Testing Services Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Bioanalytical Testing Services Market is presumed to reach the market size of nearly USD 9.77 Billion by 2032 from USD 3.89 Billion in 2023 with a CAGR of 10.78% under the study period 2024-2032.

Bioanalytical testing services encompass specialized analytical techniques used to measure & analyze biological samples, such as urine, blood, or tissue, for drug development, clinical trials, and diagnostic evaluations. These services include quantifying biomolecules, assessing pharmacokinetics, and evaluating drug interactions and efficacy. Bioanalytical testing ensures pharmaceutical and biopharmaceutical products' safety, efficacy, and quality. Techniques employed in bioanalytical testing include mass spectrometry, chromatography, and immunoassays. Accurate bioanalytical testing supports regulatory compliance and the advancement of personalized medicine.

Market Dynamics

Expanding the pharmaceutical and biotechnology sectors, focusing on drug development and personalized medicine, is a key driver, as these industries require comprehensive bioanalytical testing to ensure product safety and effectiveness. Increasing regulatory requirements and stringent guidelines for clinical trials are also contributing to the bioanalytical testing services market. Advancements in testing technologies, such as high-throughput screening and improved analytical techniques, are enhancing the accuracy and efficiency of bioanalytical services. The rise in chronic diseases and the need for innovative therapeutic solutions create a growing demand for bioanalytical testing services to support drug development and clinical research. With expanding healthcare infrastructures and increasing investment in research and development, emerging markets present new growth opportunities. Companies investing in technology upgrades and expanding their service portfolios are well-positioned to capitalize on these trends. However, the high costs associated with advanced bioanalytical testing services may hinder market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Bioanalytical Testing Services . The growth and trends of Bioanalytical Testing Services industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Bioanalytical Testing Services market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Molecule

Small Molecule
Large Molecule (LC-MS Studies, Immunoassays, PK, ADA, Others)
Others

By Test

ADME (In-Vivo, In-Vitro)
PK
PD
Bioavailability
Bioequivalence
Others

By Workflow

Sample Preparation (Protein Precipitation, Liquid-Liquid Extraction, Solid Phase Extraction)
Sample Analysis (Hyphenated Technique, Chromatographic Technique, Electrophoresis, Ligand Binding Assay, Mass Spectrometry, Nuclear Magnetic Resonance)
Other Workflow Processes

By Application

Oncology
Neurology
Infectious Diseases
Gastroenterology
Cardiology
Other Applications

By End Use

Pharma & BioPharma Companies
CDMO
CRO

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Bioanalytical Testing Services market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Bioanalytical Testing Services market include Thermo Fisher Scientific Inc (PPD Inc.), ICON Plc., Charles River Laboratories International, Covance Inc., IQVIA, Syneos Health, SGS SA, Labcorp (Toxikon), Intertek Group Plc., Pace Analytical Services LLC. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11212624

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. BIOANALYTICAL TESTING SERVICES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Molecule
- 3.7.2 Market Attractiveness Analysis By Test
- 3.7.3 Market Attractiveness Analysis By Workflow
- 3.7.4 Market Attractiveness Analysis By Application
- 3.7.5 Market Attractiveness Analysis By End Use
- 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET ANALYSIS BY MOLECULE

5.1. Overview By Molecule
5.2. Historical and Forecast Data
5.3. Analysis By Molecule
5.4. Small Molecule Historic and Forecast Sales By Regions
5.5. Large Molecule (LC-MS Studies, Immunoassays, PK, ADA, Others) Historic and Forecast Sales By Regions
5.6. Others Historic and Forecast Sales By Regions

6. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET ANALYSIS BY TEST

6.1. Overview By Test
6.2. Historical and Forecast Data
6.3. Analysis By Test
6.4. ADME (In-Vivo, In-Vitro) Historic and Forecast Sales By Regions
6.5. PK Historic and Forecast Sales By Regions
6.6. PD Historic and Forecast Sales By Regions
6.7. Bioavailability Historic and Forecast Sales By Regions
6.8. Bioequivalence Historic and Forecast Sales By Regions
6.9. Others Historic and Forecast Sales By Regions

7. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET ANALYSIS BY WORKFLOW

7.1. Overview By Workflow
7.2. Historical and Forecast Data
7.3. Analysis By Workflow
7.4. Sample Preparation (Protein Precipitation, Liquid-Liquid Extraction, Solid Phase Extraction) Historic and Forecast Sales By Regions
7.5. Sample Analysis (Hyphenated Technique, Chromatographic Technique, Electrophoresis, Ligand Binding Assay, Mass Spectrometry, Nuclear Magnetic Resonance) Historic and Forecast Sales By Regions
7.6. Other Workflow Processes Historic and Forecast Sales By Regions

8. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET ANALYSIS BY APPLICATION

8.1. Overview By Application
8.2. Historical and Forecast Data
8.3. Analysis By Application
8.4. Oncology Historic and Forecast Sales By Regions
8.5. Neurology Historic and Forecast Sales By Regions
8.6. Infectious Diseases Historic and Forecast Sales By Regions
8.7. Gastroenterology Historic and Forecast Sales By Regions
8.8. Cardiology Historic and Forecast Sales By Regions
8.9. Other Applications Historic and Forecast Sales By Regions

9. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET ANALYSIS BY END USE

9.1. Overview By End Use
9.2. Historical and Forecast Data
9.3. Analysis By End Use
9.4. Pharma & BioPharma Companies Historic and Forecast Sales By Regions
9.5. CDMO Historic and Forecast Sales By Regions
9.6. CRO Historic and Forecast Sales By Regions

10. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET ANALYSIS BY GEOGRAPHY

10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
- 10.3.1 Overview, Historic and Forecast Data Sales Analysis
- 10.3.2 North America By Segment Sales Analysis
- 10.3.3 North America By Country Sales Analysis
- 10.3.4 United States Sales Analysis
- 10.3.5 Canada Sales Analysis
- 10.3.6 Mexico Sales Analysis
10.4. Europe Sales Analysis
- 10.4.1 Overview, Historic and Forecast Data Sales Analysis
- 10.4.2 Europe By Segment Sales Analysis
- 10.4.3 Europe By Country Sales Analysis
- 10.4.4 United Kingdom Sales Analysis
- 10.4.5 France Sales Analysis
- 10.4.6 Germany Sales Analysis
- 10.4.7 Italy Sales Analysis
- 10.4.8 Russia Sales Analysis
- 10.4.9 Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
- 10.5.1 Overview, Historic and Forecast Data Sales Analysis
- 10.5.2 Asia Pacific By Segment Sales Analysis
- 10.5.3 Asia Pacific By Country Sales Analysis
- 10.5.4 China Sales Analysis
- 10.5.5 India Sales Analysis
- 10.5.6 Japan Sales Analysis
- 10.5.7 South Korea Sales Analysis
- 10.5.8 Australia Sales Analysis
- 10.5.9 South East Asia Sales Analysis
- 10.5.10 Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
- 10.6.1 Overview, Historic and Forecast Data Sales Analysis
- 10.6.2 Latin America By Segment Sales Analysis
- 10.6.3 Latin America By Country Sales Analysis
- 10.6.4 Brazil Sales Analysis
- 10.6.5 Argentina Sales Analysis
- 10.6.6 Peru Sales Analysis
- 10.6.7 Chile Sales Analysis
- 10.6.8 Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
- 10.7.1 Overview, Historic and Forecast Data Sales Analysis
- 10.7.2 Middle East & Africa By Segment Sales Analysis
- 10.7.3 Middle East & Africa By Country Sales Analysis
- 10.7.4 Saudi Arabia Sales Analysis
- 10.7.5 UAE Sales Analysis
- 10.7.6 Israel Sales Analysis
- 10.7.7 South Africa Sales Analysis
- 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE BIOANALYTICAL TESTING SERVICES COMPANIES

11.1. Bioanalytical Testing Services Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments

12. COMPANY PROFILES OF BIOANALYTICAL TESTING SERVICES INDUSTRY

12.1. Top Companies Market Share Analysis
12.2. Market Concentration Rate
12.3. Thermo Fisher Scientific Inc (PPD Inc.)
- 12.3.1 Company Overview
- 12.3.2 Company Revenue
- 12.3.3 Products
- 12.3.4 Recent Developments
12.4. ICON Plc.
- 12.4.1 Company Overview
- 12.4.2 Company Revenue
- 12.4.3 Products
- 12.4.4 Recent Developments
12.5. Charles River Laboratories International
- 12.5.1 Company Overview
- 12.5.2 Company Revenue
- 12.5.3 Products
- 12.5.4 Recent Developments
12.6. Covance Inc.
- 12.6.1 Company Overview
- 12.6.2 Company Revenue
- 12.6.3 Products
- 12.6.4 Recent Developments
12.7. IQVIA
- 12.7.1 Company Overview
- 12.7.2 Company Revenue
- 12.7.3 Products
- 12.7.4 Recent Developments
12.8. Syneos Health
- 12.8.1 Company Overview
- 12.8.2 Company Revenue
- 12.8.3 Products
- 12.8.4 Recent Developments
12.9. SGS SA
- 12.9.1 Company Overview
- 12.9.2 Company Revenue
- 12.9.3 Products
- 12.9.4 Recent Developments
12.10. Labcorp (Toxikon)
- 12.10.1 Company Overview
- 12.10.2 Company Revenue
- 12.10.3 Products
- 12.10.4 Recent Developments
12.11. Intertek Group Plc.
- 12.11.1 Company Overview
- 12.11.2 Company Revenue
- 12.11.3 Products
- 12.11.4 Recent Developments
12.12. Pace Analytical Services LLC
- 12.12.1 Company Overview
- 12.12.2 Company Revenue
- 12.12.3 Products
- 12.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies